| GSK J1 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1373422-53-7 |
| N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester |
N-[(S)-(2,3,4,5,6-五氟苯氧基)苯氧基磷酰基]-L-丙氨酸异丙酯 |
1334513-02-8 |
| CH5132799 |
CH5132799 |
1007207-67-1 |
| JZL 184 |
JZL-184 |
1101854-58-3 |
| BAZEDOXIFENE ACETATE |
醋酸巴多昔芬 |
198481-33-3 |
| Deracoxib |
地拉考昔 |
169590-41-4 |
| Wnt Agonist |
WNT AGONIST 1 (CID11210285 盐酸盐) |
853220-52-7 |
| PF 04217903 mesylate |
PF 04217903 MESYLATE |
956906-93-7 |
| PD04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
| Danirixin |
GSK1325756 |
954126-98-8 |
| LY2409881 trihydrochloride |
IKK2抑制剂（LY2409881） |
946518-60-1 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| PACRITINIB |
帕克替尼 |
937272-79-2 |
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| Acetic acid, 2-[2-[2-(2-propyn-1-yloxy)ethoxy]ethoxy]- |
2-(2-(2-(丙-2-炔-1-基氧基)乙氧基)乙氧基)乙酸 |
944561-46-0 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
| Canagliflozin heMihydrate |
卡格列净半水合物 |
928672-86-0 |
| SAR407899 |
SAR407899 |
923359-38-0 |
QQ
微信
